DURVALUMAB

21581 reported adverse events

Drug classes: Programmed Death Ligand-1 Blocker [EPC]

These side effects are most commonly reported by patients taking DURVALUMAB:

# Side effect Count
0 DEATH 4160
1 MALIGNANT NEOPLASM PROGRESSION 1703
2 PNEUMONITIS 900
3 RADIATION PNEUMONITIS 812
4 DIARRHOEA 700
5 PYREXIA 670
6 OFF LABEL USE 616
7 PNEUMONIA 500
8 DYSPNOEA 495
9 INTERSTITIAL LUNG DISEASE 491
See all common reactions for DURVALUMAB

DURVALUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPITHELITIS 16 0.7619
1 RADIATION PNEUMONITIS 812 0.3791
2 OESOPHAGOMEDIASTINAL FISTULA 7 0.3500
3 DIFFUSE UVEAL MELANOCYTIC PROLIFERATION 6 0.3158
4 BILE DUCT CANCER RECURRENT 7 0.2500
5 NON-SMALL CELL LUNG CANCER RECURRENT 64 0.2261
6 IMMUNOTOXICITY 22 0.1930
7 PULMONARY RADIATION INJURY 11 0.1803
8 TUMOUR HYPERPROGRESSION 36 0.1452
9 LUNG SQUAMOUS CELL CARCINOMA RECURRENT 6 0.1395
See all enriched reactions for DURVALUMAB